OSCR Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
4.9B
+6.4%
4.6B
+66.4%
2.8B
-6.0%
2.9B
+2.4%
2.9B
Cost of Revenue
3.8B
+17.5%
3.2B
+23.3%
2.6B
+1.3%
2.6B
+1.3%
2.6B
Gross Profit
1.1B
-20.0%
1.4B
+900.9%
135.6M
-60.9%
346.4M
+11.4%
311.0M
Operating Expenses
697.1M
-2.3%
713.3M
+37.5%
518.9M
-1.9%
528.9M
-2.3%
541.5M
R&D
0
0
0
0
0
SG&A
697.1M
-2.3%
713.3M
+37.5%
518.9M
-1.9%
528.9M
-2.3%
541.5M
Operating Income
388.6M
-39.6%
643.5M
+267.9%
-383357000
-110.1%
-182465000
+20.8%
-230483000
EBITDA
394.7M
-39.3%
650.5M
+273.2%
-375477000
-114.4%
-175153000
+21.6%
-223513000
Net Income
361.8M
-46.7%
679.0M
+292.7%
-352434000
-156.3%
-137484000
+39.8%
-228491000
EPS (Basic)
$1.20
-47.4%
$2.28
+283.9%
$-1.24
-134.0%
$-0.53
+40.4%
$-0.89
EPS (Diluted)
$1.10
-46.9%
$2.07
+234.4%
$-1.54
-190.6%
$-0.53
+40.4%
$-0.89
Shares (Diluted)
333.4M
+1.1%
329.8M
+44.1%
228.8M
-11.7%
259.3M
+1.5%
255.5M
Oscar Health (OSCR) โ€” Financials